Literature DB >> 26884845

Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.

Nan Zhao1, Bao-Cun Sun2, Xiu-Lan Zhao1, Yong Wang3, Jie Meng1, Na Che1, Xu-Yi Dong1, Qiang Gu1.   

Abstract

OBJECTIVE: An investigation of the role of the anti-apoptotic protein Bcl-2 and its associated miRNAs in vasculogenic mimicry (VM) in hepatocellular carcinoma.
METHODS: The Bcl-2 expression plasmid was constructed for transfection into the hepatocellular carcinoma cell line HepG2. Changes in the expression profiles of the miRNAs induced by Bcl-2 overexpression and their relationships with vasculogenic mimicry were analysed. Real-time PCR was performed in frozen tissue specimens from 42 cases of hepatocellular carcinoma to analyse the relationship between Bcl-2 and miR-27a; Immunohistochemical staining was performed in paraffin-embedded tissue samples from 97 cases of hepatocellular carcinoma to analyse the relationship between Bcl-2 expression and the expression of vasculogenic mimicry (VM) related molecules VEGF and HIF1A, which were target genes of the Bcl-2 related miRNAs.
RESULTS: Overexpression of Bcl-2 results in a significant change in the expression of a wide range of miRNAs, and the target genes of these miRNAs are composed of various vasculogenic mimicry related genes; Bcl-2 expression was positively correlated with the expression of the miRNA target genes VEGF and HIF1A. The expression of VEGF and HIF1A was significantly and positively correlated with VM and poor prognosis of patients.
CONCLUSION: Bcl-2 may play a role in vasculogenic mimicry through miRNAs by targeting angiogenesis associated genes.

Entities:  

Keywords:  Bcl-2; HIF1A; VEGF; hepatocellular carcinoma; miRNA; vasculogenic mimicry

Mesh:

Substances:

Year:  2015        PMID: 26884845      PMCID: PMC4730058     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  Targeting apoptosis for anticancer therapy.

Authors:  Simone Fulda
Journal:  Semin Cancer Biol       Date:  2014-05-22       Impact factor: 15.707

2.  MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.

Authors:  Pasquale Fasanaro; Yuri D'Alessandra; Valeria Di Stefano; Roberta Melchionna; Sveva Romani; Giulio Pompilio; Maurizio C Capogrossi; Fabio Martelli
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

3.  BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

Authors:  Chiara Gabellini; Teresa De Luca; Daniela Trisciuoglio; Marianna Desideri; Marta Di Martile; Daniela Passeri; Antonio Candiloro; Mauro Biffoni; Maria Giulia Rizzo; Augusto Orlandi; Donatella Del Bufalo
Journal:  Carcinogenesis       Date:  2013-07-08       Impact factor: 4.944

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.

Authors:  Robert L Foote; Noel Weidner; Jonathan Harris; Elizabeth Hammond; Jean E Lewis; Te Vuong; K Kian Ang; Karen K Fu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

6.  Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.

Authors:  Angela Iervolino; Daniela Trisciuoglio; Domenico Ribatti; Antonio Candiloro; Annamaria Biroccio; Gabriella Zupi; Donatella Del Bufalo
Journal:  FASEB J       Date:  2002-07-01       Impact factor: 5.191

7.  Study of the vascular endothelial growth factor (VEGF) expression and microvascular density (MVD) in primary colorectal cancer specimens.

Authors:  Sahaphol Anannamcharoen; Thirayost Nimmanon
Journal:  J Med Assoc Thai       Date:  2012-08

8.  Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species.

Authors:  Ning Gao; Min Ding; Jenny Z Zheng; Zhuo Zhang; Stephen S Leonard; Ke Jian Liu; Xianglin Shi; Bing-Hua Jiang
Journal:  J Biol Chem       Date:  2002-06-17       Impact factor: 5.157

9.  VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.

Authors:  Mario Scartozzi; Luca Faloppi; Gianluca Svegliati Baroni; Cristian Loretelli; Fabio Piscaglia; Massimo Iavarone; Pierluigi Toniutto; Giammarco Fava; Samuele De Minicis; Alessandra Mandolesi; Maristella Bianconi; Riccardo Giampieri; Alessandro Granito; Floriana Facchetti; Davide Bitetto; Sara Marinelli; Laura Venerandi; Sara Vavassori; Stefano Gemini; Antonietta D'Errico; Massimo Colombo; Luigi Bolondi; Italo Bearzi; Antonio Benedetti; Stefano Cascinu
Journal:  Int J Cancer       Date:  2014-02-20       Impact factor: 7.396

Review 10.  Clinically relevant microRNAs in ovarian cancer.

Authors:  Shu Zhang; Zhen Lu; Anna K Unruh; Cristina Ivan; Keith A Baggerly; George A Calin; Zongfang Li; Robert C Bast; Xiao-Feng Le
Journal:  Mol Cancer Res       Date:  2014-10-10       Impact factor: 5.852

View more
  16 in total

1.  Vasculogenic mimicry and expression of ALDH1, Beclin1, and p16 correlate with metastasis and prognosis in oral squamous cell carcinoma.

Authors:  Yichao Wang; Xiaolin Wang; Yu Zhang; Lan Yu; Bo Zhu; Shiwu Wu; Danna Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 2.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

3.  Recurrent and metastatic extragastrointestinal stromal tumors of the mesentery with C-KIT and PDGFRA mutations: a case report.

Authors:  Huang Yayu; Zhang Changmao; Dai Yijun; Lin Na; Xu Tianwen; Dai Yangbin
Journal:  Cancer Biol Ther       Date:  2019-10-10       Impact factor: 4.742

4.  The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.

Authors:  Zhengqi Bao; Zenong Cheng; Damin Chai
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

5.  TDB protects vascular endothelial cells against oxygen-glucose deprivation/reperfusion-induced injury by targeting miR-34a to increase Bcl-2 expression.

Authors:  Li-Xi Liao; Ming-Bo Zhao; Xin Dong; Yong Jiang; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

6.  Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma.

Authors:  Lan Yu; Bo Zhu; Shiwu Wu; Lei Zhou; Wenqing Song; Xiaomeng Gong; Danna Wang
Journal:  Diagn Pathol       Date:  2017-03-02       Impact factor: 2.644

7.  Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer.

Authors:  Xiaolan You; Yuanjie Wang; Jian Wu; Qinghong Liu; Dehu Chen; Dong Tang; Daorong Wang
Journal:  Onco Targets Ther       Date:  2018-05-29       Impact factor: 4.147

8.  Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.

Authors:  Bo Zhu; Lei Zhou; Lan Yu; Shiwu Wu; Wenqing Song; Xiaomeng Gong; Danna Wang
Journal:  BMC Surg       Date:  2017-04-21       Impact factor: 2.102

9.  Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells.

Authors:  Chao Ma; Ling-Ling Zhao; Heng-Jun Zhao; Jiu-Wei Cui; Wei Li; Nan-Ya Wang
Journal:  Mol Med Rep       Date:  2018-02-16       Impact factor: 2.952

10.  Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer.

Authors:  Sen Wang; Zhiyuan Zhang; Wenwei Qian; Dongjian Ji; Qingyuan Wang; Bing Ji; Yue Zhang; Chuan Zhang; Ye Sun; Chunyan Zhu; Yueming Sun
Journal:  Onco Targets Ther       Date:  2018-07-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.